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Increasing evidences indicate involvement of free radicals in the pathogenesis of  benign and 
malignant breast diseases. Free radicals are highly reactive molecules and react   with non–radicals in 
chain reaction leading to formation of new free radicals. If the defense mechanism of body fails to 
combat them, these free radicals pose a threat of injuring tissues by reacting with cell lipids.  Lipids in 
the cell membrane undergo degradation to form hydroperoxides, which decompose to form a variety 
of products including malondialdehyde (MDA). MDA therefore was used as a marker to assess 
oxidative damage of cells and tissues. The aim of the present study was to assess the status of 
oxidative stress in the patients of benign and malignant breast diseases. Study has been made on the 
blood samples of 25 cases of benign breast disease and on an equal number of breast carcinoma 
patients. 20 healthy subjects were taken as the control cases.
Mean MDA levels were significantly raised with depletion of antioxidant activity in all the patients 
in comparison to their control group suggesting the role of oxidative damage in the aetiopathogenesis 
of disease.
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Oxidative stress is involved in the development 
of over a hundred pathologies, including cancer 
(Pincemail   et   al,   1998).   Generally   speaking, 
oxidative stress is defined as an imbalance between 
the level of prooxidants (activated oxygen species 
or   AOS)   and   an   organism's   defence   systems 
(antioxidants), in favour of the former and resulting 
in irreversible  cell  damage.  When produced in 
excess, AOS (some of which are free radicals) can 
seriously alter the structure of biological substrates 
such   as   proteins,   lipids,   lipoproteins,   and 
deoxyribonucleic acid (DNA). Oxidation of the 
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constitutive   bases   of   DNA   (formation   of   the 
oxidised base 8-hydroxy-2'guanosine or 8OHdG) 
by   AOS   produced   in   various   ways   (action   of 
chemical carcinogens, ionizing radiation, ultraviolet 
radiation) is thus involved in cancer development to 
a   considerable   extent  (Pincemail   et   al,   1999). 
Recent findings in molecular biology have shown, 
however, that AOS also play other important roles 
in cells (Gonzalez, 1999).
We have measured the levels of oxidative stress 
along with the status of antioxidant enzymes in the 
serum  of the benign breast  disease and breast 
carcinoma patients. Healthy subjects were taken as 
the control cases to assess the oxidative damage in 
the patients and also to assess clinico-pathological 
correlation at the time of their initial presentation.
MATERIALS AND METHODS
The study was conducted with the blood from 
two groups of   patients   of benign breast disease, 
n=25 and malignant disease, n=25 admitted in the 
University   Hospital,   Banaras   Hindu   University, 
Varanasi. Age and sex matched healthy individuals 
were selected as controls (n =20). Informed consent 
was taken from the patients or their attendants in all 
the cases. 
Collection of Blood Samples: 
Blood   samples   were   collected   from   the 
antecubital   vein   of   the   above   stated   subjects. 
Venous blood sample about 5 ml was collected in 
the clean and dry plain vials. Thereafter it was 
separated by centrifugation at 2000 rpm in a clinical 
centrifuge   for   10-15   minutes.   The   serum,   thus 
removed, was stored at -20  
0C in a sterile plain 
glass vial until analyzed. 
Estimation of Malondialdehyde
Serum   malondialdehyde   (marker   of   lipid 
peroxidation) levels in the cases and controls were 
assayed by thiobarbituric acid reactive substances 
(TBARS) technique of Burge and Aust (1978).
Estimation of total antioxidant status (TAS)
The   serum   total   antioxidant   status   was 
determined using Randox assay kit  (Miller et al, 
1993). The assay based on the principle that ABTS 
(2, 2’-Azino-di-[3-ethylbenzthiazoline sulphonate]) 
is incubated with a peroxidase and H2O2 to produce 
the radical cation ABTS
+. This has a relatively 
stable blue green colour which is measured at 
600nm. Antioxidant in the cord blood causes the 
suppression of this  color  production to a degree 
which is proportional to their concentration.
Statistical Analysis:
Statistical analysis was done using statistical 
software SPSS version 10.0. Data was found to be 
normally distributed.  Paired  ‘t’ test, ANOVA test 
and SNK test were applied and the results were 
referred as mean ± SD and p value was considered 
significant at 5% level of significance.
Table 1: Comparison of serum MDA and total antioxidants in cases of benign and malignant breast 
disease. 
Group No. of 
patients
    MDA  (mmol/L)
  Mean±SD    
t-value   
 (p-value)
Total Antioxidant 
(mmol/L) Mean ±SD
t-value 
(p-value)
Malignant 25 0.905±0.208 2.638 
(0.011)
1.253±0.579
1.140 
 (0.260)
Benign 25 0.730±0.257 1.451±0.646
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Table 2: Comparison of serum MDA and total antioxidants in cases of malignant breast disease and 
controls
Group
No. of 
patients
MDA (mmol/L) 
(Mean ± SD)
t-value
(p-value)
Total Antioxidant
(mmol/L) (Mean±SD)
t-value 
(p-value)
Malignant 25 0.905±0.208 3.125
(0.009)
1.253±0.579 1.739 
(0.089) Control 20 0.714±0.180 1.5042±0.509
Table 3: Comparison of serum MDA and total antioxidants in cases of benign breast disease and 
controls
Group
No. of 
patients
MDA (mmol/L)
(Mean±SD)
t-value
(p-value)
Total antioxidant (mmol/L)
 (Mean±SD)
t-value
(p-value)
Benign 25 0.730±0.257 0.654
 (0.521)
1.451±0.646 0.0426
 (0.672) Control 20 0.714±0.180 1.5042±0.509
RESULTS
The present study included 50 patients of breast 
disease, constituting 25 cases of benign and an equal 
number of malignant cases treated in the Department 
of   Surgery,   University   Hospital,   Banaras   Hindu 
University, Varanasi. Study also included 20 healthy 
females who acted as age matched controls. The 
consent of each individual was taken purely for 
research work.
The average age of breast cancer patients in our 
study was 48.3 yrs. The youngest patient of breast 
cancer was 35 yrs old while the oldest patient was of 
64 yrs. The average age of patients with benign 
breast disease was 32.3 yrs.   The youngest and 
oldest being of 14 yrs and 45 yrs respectively. These 
figures   depict   that   relatively   younger   subset   of 
female   population   is   exposed   to   benign   breast 
diseases while the older females were exposed to 
malignant disease. While more than half of the 
patients of breast carcinoma were post menopausal , 
all the patients in benign breast disease group were 
pre-menopausal.
The most common presentation for breast disease 
whether benign or malignant in this study was a 
palpable   lump   (100%).   Even   distribution   of 
involvement   of side  was  seen  in  benign  breast 
disease   and   malignant   group.   Majority   of   the 
patients in both the groups had left sided disease. 
Histologically almost all the cases (24 out of 25) of 
carcinoma breast were infiltrating ductal carcinoma 
while   histopathology   of   benign   breast   disease 
revealed fibroadenoma in more than half of the 
cases.   All the patients in the study had either 
stage II or stage III disease. 15 (60%) out 25 
patients of breast cancer in this study had stage III 
disease. 
The   serum   concentration   of   malondialdehyde 
was significantly higher in carcinoma patients in 
comparison to those in benign and control group. 
Raised level of malondialdehyde in breast cancer 
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patients is marker for higher levels of free radical 
damage in these patients. 
The estimation of total antioxidant which denotes 
the resistance in body to oxidative damage revealed 
lower concentration in malignancy as compared to 
benign group and controls. 
The combination of higher concentration of free 
radicals   and   lower   values   of   antioxidants 
concentration in cases of breast cancer creates a 
picture of increased oxidative stress. Oxidative stress 
by definition is the difference between pro-oxidants 
and antioxidants, which in this study is observed to 
be higher in breast carcinoma as compared to benign 
breast diseases. 
DISCUSSION
Oxidative stress is a condition which modifies 
the normal intracellular balance between oxidant 
substances produced during aerobic metabolism and 
antioxidant  system  processes  which  perform  the 
function   of   neutralization,   putting   a   series   of 
protective mechanisms, of both an enzymatic and 
non-enzymatic nature, in action. Enzymatic systems 
include   superoxide   dismutase   (SOD),   catalase 
(CAT) and glutathione peroxidase (GSH-Px). In 
non-enzymatic   systems,   the   most   important 
molecules are glutathione, alpha-tocopherol (vitamin 
E), ascorbic acid (vitamin C), flavonoids, the phenol 
compounds and the minerals zinc (Zn), copper (Cu) 
and selenium (Se)  (Halliwell, Gutteridge, 2007). 
Numerous physiological and pathological processes 
such as ageing, excessive caloric intake, infections, 
inflammatory   disorders,   environmental   toxins, 
pharmacological   treatments,   emotional   or 
psychological   stress,   ionizing   radiation,   cigarette 
smoke and alcohol increase the bodily concentration 
of oxidizing substances, known as reactive oxygen 
species (ROS) or, more commonly, free radicals. 
These are chemical species which are highly reactive 
owing to the presence of free unpaired electrons. An 
increase in free radicals compromises the delicate 
homeostatic   mechanisms   which   involve 
neurotransmitters, hormones, oxidizing substances 
and   numerous   other   mediators.   Owing   to   their 
structure,   which     is   rich   in   double   bonds, 
polyunsaturated fatty acids (PUFAs) render cellular 
membranes vulnerable to damage from free radicals, 
causing peroxidation. The damage induced by lipid 
peroxidation renders the cell unstable, and therefore 
compromises   fluidity,   permeability,   signal 
transduction   and   causes   receptor,   mitochondrial 
DNA and nuclear alterations.
In   the   present   study,   mean   concentration   of 
MDA was compared between benign (0.730±0.257 
mmol/L)   and   malignant   (0.905±0.208   mmol/L) 
groups, a statistically significant difference   was 
established (p=0.011).  The analysis points to higher 
concentration   of   MDA   in   serum   of   malignant 
patients than those in benign breast disease group. 
Similarly,   comparison   of   mean   concentration   of 
MDA of breast cancer patients and control group 
revealed   statistically   significant   difference 
(p=0.009).  The  mean concentration  of MDA in 
patients of breast cancer was 0.905±0.208 mmol/L 
and in control group 0.714±0.180. This reinforces 
the higher concentration of free radicals in breast 
cancer patients. 
Total antioxidant status of an individual is a 
measure of defense against free radical damage. The 
mean concentration of total antioxidants was lower 
in   carcinoma   breast   patients   (1.253±0.579 
mmol/L)   than   their   benign   counter   part 
(1.451±0.646   mmol/L)   and   healthy   control 
(1.5042±0.509 mmol/L). These findings depict a 
weak protection offered by body to the exposure of 
oxidative   damage   by   free   radicals   and   points 
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towards   the   significant   role   of   free   radicals   in 
carcinogenesis. 
CONCLUSION
Our study indicates that there is an association 
between increased oxidative stress and the benign 
breast   disease   and   breast   carcinoma   disorders. 
Morphological, biochemical and molecular studies 
reveal that oxidative stress plays a primary role in 
the development of degenerative changes in the cells 
and tissues of our body. Since all the cells and 
tissues of our body are also equipped with anti 
oxidative   enzymes   like   super   oxide   dismutase 
(SOD),   glutathione   peroxidase   (GPX),glutathione 
reductase   (GRd)   and   substances   like   reduced 
glutathione (GSH), they dispose the free radicals as 
and when they are generated thereby protecting the 
cells and tissues from the oxidative attack. Normally 
a balance is maintained between the oxidative attack 
of the free radicals and the antioxidative defense 
system prevailing in the cells and tissues of body. 
But when  the  balance is tilted more towards the 
generation   of   free   radicals,   then   degenerative 
changes cause many degenerative diseases including 
cancer.
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